Skip to content
Medical Health Aged Care

Memory Walk & Jog is heading to Sydney!

Dementia Australia 2 mins read

What started as one event has grown to a movement across Australia, and in six weeks Memory Walk & Jog will take place in Sydney!

 

Dementia Australia’s largest fundraising event is heading back to Sydney after a great event last year with walkers, runners and joggers setting off on Sunday 19 May at Leichardt Oval #3, Lilyfield. Last year, more than 10,000 people walked, jogged and ran in cities and towns across Australia for people impacted by dementia. This year we’re hoping to go even bigger and want more people to sign-up and assist us in raising more than $2 million which will help fund invaluable support, education and resources for people living with dementia in Australia, their families and carers.

 

There are more than 421,000 people of all ages living with dementia in Australia. Without a medical breakthrough, the number of people living with dementia is expected to increase to more than 812,500 by 2054. Dementia is the second leading cause of death in Australia and the leading cause of death for women. Memory Walk & Jog plays an important role not only in funding support, but also in raising awareness of dementia.    

 

 Walk or jog with us. We are in this together. 

 

Sign-up to walk, jog or run, or join in as a Volunteer, at a Memory Walk & Jog event at www.memorywalk.com.au. Share your Memory Walk & Jog experience on your socials and Donate today to support people living with dementia across Australia. 

 

If you can’t attend an event, why not organise your own group or individual walk or jog, with a My Way event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw.

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

 

-Ends-

Media contacts: Andrea Hogan, Media and Communications Manager, 0406 904 118, andrea.hogan@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors: Photos and video of previous Memory Walk & Jog events are available for publication. 

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 15/09/2024
  • 07:05
Royal Australian College of GPs

Over 200 new specialist GPs awarded Fellowship in Victoria

Australia’s leading GP training college, the Royal Australian College of GPs (RACGP) welcomed 215 new fellows as specialist general practitioners at a Fellowship ceremony in Victoria on Sunday 15 September. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP, following around 11 years of education, training, rigorous assessment, and experience in primary care. The new GPs recognised at the ceremony at Pullman on the Park East Melbourne included three rural generalists, GPs who complete extra Additional Rural Skills Training in fields needed in rural practice, like anaesthesia and obstetrics . RACGP President Dr Nicole Higgins…

  • Contains:
  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:31
Dementia Australia

New report reinforces dementia as chronic disease of 21st century

Updates to the Dementia in Australia report, released today by the Australian Institute of Health and Welfare (AIHW), reinforce that dementia is an urgent public health issue. Dementia is the second leading cause of death in Australia, the leading cause of death of women, the second leading cause of disease burden overall, and the leading cause of burden for people aged 65 and over. Dementia Australia CEO Professor Tanya Buchanan saidthe report highlights the enormity and impact of dementia in Australia as the chronic disease of the 21st century. “Despite the growing number of Australians diagnosed with dementia – there…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.